JANE STREET GROUP, LLC - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 166 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2020. The put-call ratio across all filers is 1.08 and the average weighting 0.4%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2024$232,474
-84.3%
14,779
-83.9%
0.00%
Q4 2023$1,477,073
+18.7%
91,573
-6.4%
0.00%
Q3 2023$1,244,232
+31.8%
97,817
+45.9%
0.00%
Q2 2023$943,684
+11.4%
67,023
+22.2%
0.00%
Q1 2023$847,479
+82.0%
54,853
+93.0%
0.00%
Q4 2022$465,770
-67.2%
28,418
-63.0%
0.00%
-100.0%
Q3 2022$1,422,000
+400.7%
76,863
+256.5%
0.00%
Q2 2022$284,000
-64.1%
21,560
-74.8%
0.00%
Q1 2022$792,000
-71.5%
85,425
-70.0%
0.00%
Q4 2021$2,780,000
+105.2%
284,563
+614.0%
0.00%
Q3 2021$1,355,000
+232.1%
39,853
+337.9%
0.00%
Q1 2021$408,000
-73.5%
9,100
-66.3%
0.00%
-100.0%
Q4 2020$1,542,000
+94.5%
26,999
+74.7%
0.00%
Q3 2020$793,000
-24.8%
15,457
-12.5%
0.00%
Q2 2020$1,055,000
+13.9%
17,671
+18.8%
0.00%
-100.0%
Q4 2019$926,000
+336.8%
14,872
+137.9%
0.00%
Q3 2019$212,000
-80.9%
6,252
-77.9%
0.00%
-100.0%
Q2 2018$1,112,00028,2640.00%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q3 2020
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$19,824,86914.35%
Redmile Group, LLC 3,593,317$58,894,4662.41%
BRAIDWELL LP 3,271,513$53,620,0981.80%
Parkman Healthcare Partners LLC 344,920$5,653,2391.50%
ARMISTICE CAPITAL, LLC 5,172,000$84,769,0801.48%
Ikarian Capital, LLC 367,119$6,017,0811.45%
Sunesis Advisors, LLC 96,299$1,578,3411.01%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,349,228$38,503,8470.80%
Hillsdale Investment Management Inc. 328,200$5,379,1980.46%
Avidity Partners Management LP 1,126,000$18,455,1400.40%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders